Cardiac-Focused Multi-Organ Chips: Advanced Disease Modeling, Drug Testing, and Inter-Organ Communication

Xiaolong Zhang1,2, Yushen Wang1,2, Junlei Han1,2

  • 1School of Mechanical Engineering, Qilu University of Technology (Shandong Academy of Sciences), Jinan, 250 353, China.

Advanced Biology
|February 6, 2025
PubMed

Insights

New multi-organ chip technology offers a better way to study heart disease. This advanced model better replicates heart function and interactions with other organs for improved research.

Area of Science:

  • Biomedical Engineering
  • Cardiovascular Research
  • Organ-on-a-Chip Technology

Background:

  • Heart disease is a major global health issue, with current research models having limitations in replicating complex cardiac functions.
  • Cardiac pathology is influenced by systemic factors and interactions between multiple organs.
  • There is a need for advanced in vitro models that better mimic the human body's complexity.

Purpose of the Study:

  • To review the advancements in cardiac-focused multi-organ chip technology.
  • To highlight the applications of this technology in understanding heart disease.
  • To discuss the future potential of multi-organ chips in medical research.

Main Methods:

  • Review of existing literature on cardiac organ chips and multi-organ systems.
  • Exploration of the technology's ability to recreate cardiac microenvironment and inter-organ communication.
  • Analysis of applications in disease modeling and drug toxicity assessment.

Main Results:

  • Cardiac-focused multi-organ chip technology provides a more accurate in vitro model for studying heart disease.
  • This technology allows for the investigation of complex inter-organ communications.
  • It enables more precise disease modeling and drug toxicity assessment compared to traditional methods.

Conclusions:

  • Multi-organ chip technology represents a significant advancement in cardiovascular research.
  • It offers a powerful tool for understanding the systemic influences on heart disease.
  • The technology holds great promise for future therapeutic evaluation and personalized medicine.